← Back to Patent Explorer
US5063242A Expired / Lapsed US ⏱️ 0.0 years remaining

7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents

Assignee: Warner Lambert Co LLC
•
Filing: 1990-07-11
•
Granted: 1991-11-05
•
Expires: 2010-07-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods for using substituted phenoxy-, 1-, and 2-naphthalenyloxy-, indenyl-, indolyl-, benzo[b]-furanyl-, and benzo[b]thienylcarboxamides of 7,8-(substituted-diamino)-1-oxaspiro[4.5]decanes as cerebrovascular, diuretic, and antiinflammatory agents are disclosed. Pharmaceutical compositions employing the compounds are also disclosed.

Inventors

  • 👤 David C. Horwell
  • 👤 David C. Rees

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 03:07
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40; A61K31/335; A61K31/34; A61K31/38; A61K31/403; A61K31/404; A61K31/405; A61K31/41; A61K31/435; A61K31/44; A61K31/445

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 248 words
A method for treating inflammation which comprises administering to a patient in need of said treatment a therapeutically effective amount of a compound in unit dosage form of formula ##STR13## or a pharmaceutically acceptable salt thereof, wherein n is an integer of from one to six; either of X or Y is oxygen and the other is --CH 2 --; R is selected from ##STR14## where R 4 and R 5 are independently hydrogen, fluorine, chlorine, bromine, nitro, trifluoromethyl, alkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, or aryl; b) 3,4,5-trimethylphenoxy; ##STR15## where R 6 is hydrogen, fluorine, chlorine, alkyl of from one to six carbon atoms, or aryl; Z is --CH 2 --, --O--, --S--, or --NR 7 -- where R 7 is hydrogen, alkanoyl of from one to six carbon atoms, or alkyl of from one to six carbon atoms; ##STR16## wherein R 8 and R 9 are independently hydrogen, fluorine, bromine, alkyl of from one to six carbon atoms, or alkoxy of from one to four carbon atoms; or ##STR17## where R 8 and R 9 are as defined above; where R 2 is methyl and R 3 is hydrogen, alkyl of from one to six carbon atoms, ##STR18## where R 10 is alkyl of from one to four carbon atoms; or where R 2 and R 3 when taken together with the nitrogen atom to which they are attached, form a pyrrolidinyl, piperidinyl, or hexahydro-1H-azepinyl ring.
Claim 2
Independent Claim 248 words
A method for treating inflammation which comprises administering to a patient in need of said treatment a therapeutically effective amount of a compound in unit dosage form of formula ##STR13## or a pharmaceutically acceptable salt thereof, wherein n is an integer of from one to six; either of X or Y is oxygen and the other is --CH 2 --; R is selected from ##STR14## where R 4 and R 5 are independently hydrogen, fluorine, chlorine, bromine, nitro, trifluoromethyl, alkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, or aryl; b) 3,4,5-trimethylphenoxy; ##STR15## where R 6 is hydrogen, fluorine, chlorine, alkyl of from one to six carbon atoms, or aryl; Z is --CH 2 --, --O--, --S--, or --NR 7 -- where R 7 is hydrogen, alkanoyl of from one to six carbon atoms, or alkyl of from one to six carbon atoms; ##STR16## wherein R 8 and R 9 are independently hydrogen, fluorine, bromine, alkyl of from one to six carbon atoms, or alkoxy of from one to four carbon atoms; or ##STR17## where R 8 and R 9 are as defined above; where R 2 is methyl and R 3 is hydrogen, alkyl of from one to six carbon atoms, ##STR18## where R 10 is alkyl of from one to four carbon atoms; or where R 2 and R 3 when taken together with the nitrogen atom to which they are attached, form a pyrrolidinyl, piperidinyl, or hexahydro-1H-azepinyl ring.
Claim 3
Dependent Claim 11 words
A method according to claim 1 wherein the compound is (-)-(5α,7α,8β)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-4benzo[b]furanacetamide.
Claim 4
Dependent Claim 26 words
A method according to claim 1 wherein 0.001 mg to 1 mg/kg of weight per day of the compound or the pharmaceutically acceptable salt is administered.

References Cited (Backward Citations)

US4499286A Cited
US4598087A Cited
US4737493A Cited
US4663343A Cited
EP0254545B1 Cited
EP0258095A1 Cited
EP0258096A2 Cited
EP0260041A1 Cited
EP0260555A1 Cited
EP0261842A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-11-04 1995-05-06 1995-11-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-11-04 1999-05-06 1999-11-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-11-04 2003-05-06 2003-11-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag